StemInov is a spin-off from the Nancy CHRU and the University of Lorraine, created in January 2019 by Pr Danièle Bensoussan and Julie Hutin. StemInov develops and produces a biomedicine for innovative therapy in inflammatory pathologies and has strong expertise in cell therapy and in particular in stem cells. In 2019, StemInov was the winner of the i-lab competition. Labeled deeptech, the company has also benefited from a French Tech grant and deeptech development aid. In December 2020, the company raised nearly one million euros from Bpifrance and Finovam Gestion via Fira Nord Est.